Germany's CureVac announced Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech and...
from NDTV News - World-news https://ift.tt/3y7qcgA
No comments:
Post a Comment